MPI and Oncology Venture are merging – here are answers to When, How, and What
Hoersholm, Denmark, June 13, 2018 – Oncology Venture AB (OV:ST) (“OV” or the “Company”) and Medical Prognosis Institute (MPI.ST) (“MPI”) today informed about details regarding the merger between MPI and Oncology VentureOn the basis of the joint merger plan adopted by the boards of Medical Prognosis Institute A/S (“MPI”) and Oncology Venture Sweden AB (“OV”) on March 9, 2018, General Meetings were held on May 30, 2018 in MPI and OV where it was unanimously decided by the represented shareholders in both companies to approve the merger plan between MPI and OV.Under Swedish law, a compulsory